Radiopharm Theranostics Limited American Depositary Shares

RADXNASDAQUSD
3.55 USD
0.74 (17.20%)AT CLOSE (11:59 AM EDT)
3.51
0.04 (1.27%)
POST MARKET (AS OF 07:34 PM EDT)
Post Market
AS OF 07:34 PM EDT
3.51
0.04 (1.27%)
🟢Market: OPEN

RADX is currently priced at $3.51. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals. Key drivers include a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.

Technical & fundamental data as of Jul 24, 2026.

Open?$2.87
High?$3.94
Low?$2.73
Prev. Close?$4.29
Volume?1.5M
Avg. Volume?N/A
VWAP?$3.13
Bid / Ask
Bid?$2.88 × 100
Ask?$4.22 × 100
Spread?$1.34
Midpoint?$3.55
Valuation & Ratios
Market Cap?33.8M
Shares Out?11.8M
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pre-clinical and clinical stages of development. The company is engaged in research, development, and commercialization of health technologies.
Employees
14
Market Cap
33.8M
Industry
N/A
Listed
2024-11-27
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-3/3)
Medium-Term (Wave)? Bearish(-2/3)
Short-Term (Ripple)? Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestModerate
Short Interest?67.0K
Days to Cover?3.5
Avg Daily Volume19.2K
Settlement Date2026-07-15